
Opportunistic Valvular Screening: How Routine ECG-AI Expands the Structural Heart Pipeline
Dr. Dereck Mush, MD, MBANo. 0 Founders & operators
Founder and CEO, Tempus AI • United States
Built Tempus into one of the largest clinical and molecular data platforms in medicine.
Find on LinkedInLefkofsky founded Tempus AI and took it public, and now speaks regularly about bringing artificial intelligence into routine diagnostics and oncology care, with the company’s data platform used across a large share of US cancer care.
Built Tempus into one of the largest clinical and molecular data platforms in medicine.
Lefkofsky founded Tempus AI and took it public, and now speaks regularly about bringing artificial intelligence into routine diagnostics and oncology care, with the company’s data platform used across a large share of US cancer care.
Loading the full dossier
Audience size across LinkedIn, X, YouTube, podcasts and newsletters.
How much the audience actually reacts, comments, shares and subscribes.
Clinical, research, operating or investing track record behind the commentary.
Publishing cadence and how reliably they show up with original work.
Whether decision makers, policy and capital actually move on what they say.
Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.
Change, add or remove details on this profile. Our desk reviews every request.
This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.

Dr. Dereck Mush, MD, MBAKeep exploring